Kuruma H - Search Results

1

[New biomarkers for the prostate cancer].

Ishii G, Kimura T, Kuruma H, Egawa S. Ishii G, et al. Among authors: kuruma h. Nihon Rinsho. 2012 May;70(5):828-32. Nihon Rinsho. 2012. PMID: 22620008 Review. Japanese.

2

Time Trends in Histological Features of Latent Prostate Cancer in Japan.

Kimura T, Takahashi H, Okayasu M, Kido M, Inaba H, Kuruma H, Yamamoto T, Furusato B, Furusato M, Wada T, Egawa S. Kimura T, et al. Among authors: kuruma h. J Urol. 2016 May;195(5):1415-1420. doi: 10.1016/j.juro.2015.11.068. Epub 2015 Dec 8. J Urol. 2016. PMID: 26678955

3

Do androgen deprivation and the biologically equivalent dose matter in low-dose-rate brachytherapy for intermediate-risk prostate cancer?

Tabata R, Kimura T, Kuruma H, Sasaki H, Kido M, Miki K, Takahashi H, Aoki M, Egawa S. Tabata R, et al. Among authors: kuruma h. Cancer Med. 2016 Sep;5(9):2314-22. doi: 10.1002/cam4.820. Epub 2016 Jul 25. Cancer Med. 2016. PMID: 27456710 Free PMC article.

4

[Prostate-specific antigen and its related parameters in detecting prostate cancer].

Kuruma H, Egawa S. Kuruma H, et al. Gan To Kagaku Ryoho. 2003 Jan;30(1):11-5. Gan To Kagaku Ryoho. 2003. PMID: 12557698 Japanese.

5

Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.

Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N, Egawa S. Kuruma H, et al. Am J Pathol. 2009 Jun;174(6):2044-50. doi: 10.2353/ajpath.2009.080776. Epub 2009 May 12. Am J Pathol. 2009. PMID: 19435788 Free PMC article.

6

[New marker proteins for prostate cancer].

Hayashi N, Kuruma H, Egawa S. Hayashi N, et al. Among authors: kuruma h. Nihon Rinsho. 2011 Jun;69 Suppl 5:140-4. Nihon Rinsho. 2011. PMID: 22207959 Review. Japanese. No abstract available.

7

Words of Wisdom: re: international variation in prostate cancer incidence and mortality rates.

Kuruma H, Egawa S. Kuruma H, et al. Eur Urol. 2013 Mar;63(3):583-4. doi: 10.1016/j.eururo.2012.12.012. Eur Urol. 2013. PMID: 23357896 No abstract available.

8

Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients.

Kimura T, Kido M, Miki K, Yamamoto T, Sasaki H, Kuruma H, Hayashi N, Takahashi H, Aoki M, Egawa S. Kimura T, et al. Among authors: kuruma h. Int J Urol. 2014 May;21(5):473-8. doi: 10.1111/iju.12347. Epub 2013 Nov 20. Int J Urol. 2014. PMID: 24256329

9

Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy.

Sasaki H, Kido M, Miki K, Kuruma H, Takahashi H, Aoki M, Egawa S. Sasaki H, et al. Among authors: kuruma h. Int J Urol. 2014 Jun;21(6):572-7. doi: 10.1111/iju.12373. Epub 2013 Dec 23. Int J Urol. 2014. PMID: 24372730

10

Pulmonary metastases after low-dose-rate brachytherapy for localized prostate cancer.

Kido M, Kuruma H, Sasaki H, Miki K, Aoki M, Kimura T, Takahash H, Kanehira C, Egawa S. Kido M, et al. Among authors: kuruma h. Korean J Urol. 2014 May;55(5):309-14. doi: 10.4111/kju.2014.55.5.309. Epub 2014 May 12. Korean J Urol. 2014. PMID: 24868334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters